Oxford University develops new Ebola vaccine for Bundibugyo outbreak in Democratic Republic of Congo
Scientists at Oxford University are developing a new Ebola vaccine using ChAdOx1 technology that could be ready within months to address an outbreak of the Bundibugyo strain in the Democratic Republic of Congo. The outbreak has caused hundreds of cases and deaths, prompting the WHO to declare a public health emergency of international concern. The vaccine, which adapts technology developed during the Covid pandemic, will require animal testing and human trials before deployment.
22
Divergence score
This event sits in the top 21% of divergence this week. 4 outlets covered it, splitting into 4 framing camps across 2 bias groups.
4 camps
2 bias groups
The spectrum · how 4 outlets placed this story
LeftCenterRight
BBC
Breitbart
Al Jazeera
The Telegraph
Supportive of action
Neutral
Dismissive
Critical
Alarmist
International angle
The split, in one line
Coverage splits between scientific urgency (BBC, Al Jazeera) and nationalist vaccine race (Breitbart, Telegraph); focus shifts from process uncertainty to treatment gaps for new Bundibugyo strain.
How each outlet covered it
Only the right is covering this
One side of the spectrum has stayed silent. That absence is itself a signal.
0
LEFT OUTLETS
0 of 4 outlets covering this story sit on that side of the spectrum.
0LEFT OUTLETS
THE RIGHT
“Ready for the Jab? Globalist Response Group Says Race for Ebola Vaccine Is On”B Breitbart RIGHT
DOWN THE MIDDLE
“Ebola outbreak: When will a vaccine be developed for the new strain?” · BBC, Al Jazeera, The Telegraph
+Hide the full sourcingSee how all 4 outlets put it
Tracked claims from across the political spectrum
Fact ledger
Corroborated
Disputed